title: Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells.
authors.forename: Noriaki
authors.initials: N
authors.lastname: Nakai
authors.forename: Norito
authors.initials: N
authors.lastname: Katoh
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kitagawa
authors.forename: Eiichiro
authors.initials: E
authors.lastname: Ueda
authors.forename: Hideya
authors.initials: H
authors.lastname: Takenaka
authors.forename: Saburo
authors.initials: S
authors.lastname: Kishimoto
mesh_terms: D000328:Adult; D000368:Aged; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate
chemical_list: D019496:Cancer Vaccines